α- and β-secretase: Profound changes in Alzheimer's disease

Biochemical and Biophysical Research Communications

Volumn 299, Issue 3, 2002, Pages 373-376

  Tyler, Susan J ^a   Dawbarn, David ^a   Wilcock, Gordon K ^b   Allen, Shelley J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Secretase; Secretase; Alzheimer's disease; Amyloid; Apolipoprotein E; BACE; Choline acetyltransferase; TACE

Indexed keywords

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CHOLINE ACETYLTRANSFERASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DEGRADATION; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; APOLIPOPROTEINS E; ASPARTIC ENDOPEPTIDASES; CHOLINE O-ACETYLTRANSFERASE; ENDOPEPTIDASES; HUMANS; STATISTICS; TEMPORAL LOBE;

EID: 0036434569     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02635-9     Document Type: Article

References (18)

1. S.J. Allen, S.H. MacGowan, S.J. Tyler, G.K. Wilcock, A.G.S. Robertson, P.H. Holden, S.K.F. Smith, D. Dawbarn, Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype, Neurosci. Lett. 239 (1997) 33-36.
2. J.D. Buxbaum, K.N. Liu, Y.X. Luo, J.L. Slack, K.L. Stocking, J.J. Peschon, R.S. Johnson, B.J. Castner, D.P. Cerretti, R.A. Black, Evidence that tumor necrosis factor a converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor, J. Biol. Chem. 273 (1998) 27765-27767.
3. M. Emre, C. Geula, B.J. Ransil, M.M. Mesulam, The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain, Neurobiol. Aging 13 (1992) 553-559.
4. F. Fonnum, A rapid radiochemical method for the determination of choline acetyltransferase activity, J. Neurochem. 24 (1975) 407-409.
5. R.M. Holsinger, C.A. McLean, K. Beyreuther, C.L. Masters, G. Evin, Increased expression of the amyloid precursor β-secretase in Alzheimer's disease, Ann. Neurol. 51 (2002) 783-786.
6. N. Hotoda, H. Koike, N. Sasagawa, S. Ishiura, A secreted form of human ADAM9 has an α-secretase activity for APP, Biochem. Biophys. Res. Commun. 293 (2002) 800-805.
7. I. Hussain, D. Powell, D.R. Howlett, D.G. Tew, T.D. Meek, C. Chapman, I.S. Gloger, K.E. Murphy, C.D. Southan, D.M. Ryan, T.S. Smith, D.L. Simmons, F.S. Walsh, C. Dingwall, G. Christie, Identification of a novel aspartic protease (Asp 2) as β-secretase, Mol. Cell. Neurosci. 14 (1999) 419-427.
8. S. Lammich, E. Kojro, R. Postina, S. Gilbert, R. PfeiDer, M. Jasionowski, C. Haass, F. Fahrenholz, Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease, Proc. Natl. Acad. Sci. USA 96 (1999) 3922-3927.
9. M. Marcinkiewicz, N.G.J. Seidah, Coordinated expression of β-amyloid precursor protein and the putative β-secretase BACE and α-secretase ADAM10 in mouse and human brain, Neurochemistry 75 (2000) 2133-2143.
10. J. Poirier, M.C. Delisle, R. Quirion, I. Aubert, M. Farlow, D. Lahiri, S. Hui, P. Bertrand, J. Nalbantoglu, B.M. Gilfix, S. Gauthier, Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease, Proc. Natl. Acad. Sci. USA 92 (1995) 12260-12264.
11. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H.S. St. George Hyslop, M.A. Perickvance, S.H. Joo, B.L. Rosi, J.F. Gusella, D.R. Crapper MacLaughlin, M.J. Alberts, C. Hulette, B. Crain, D. Goldgaber, A.D. Roses, Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease, Neurology 43 (1993) 1467-1472.
12. D.E. Schmechel, A.M. Saunders, W.J. Strittmatter, B.J. Crain, C.M. Hulette, S.H. Joo, M.A. Pericakvance, D. Goldgaber, A.D. Roses, Increased amyloid β-peptide deposition in cerebral-cortex as a consequence of apolipoprotein-E genotype in late-onset Alzheimer's disease, Proc. Natl. Acad. Sci. USA 90 (1993) 9649-9653.
13. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, M. Ikeda, H. Chi, C. Lin, G. Li, K. Holman, Cloning of a novel gene bearing missense mutations in early onset familial Alzheimer's disease, Nature 375 (1995) 754-760.
14. S. Sinha, J.P. Anderson, R. Barbour, G.S. Basi, R. Caccavello, D. Davis, M. Doan, H.F. Dovey, N. Frigon, J. Hong, K. Jacobson-Croak, N. Jewett, P. Keim, J. Knops, I. Lieberburg, M. Power, H. Tan, G. Tatsuno, J. Tung, D. Schenk, P. Seubert, S.M. Suomensaari, S. Wang, D. Walker, V. John, Purification and cloning of amyloid precursor protein β-secretase from human brain, Nature 402 (1999) 537-540.
15. M. Skovronsky, S. Fath, V.M. Lee, M.E. Milla, Neuronal localization of the TNFα converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques, J. Neurobiol. 49 (2001) 40-46.
16. R. Vassar, B.D. Bennett, S. BabuKhan, S. Kahn, E.A. Mendiaz, P. Denis, D.B. Teplow, S. Ross, P. Amarante, R. LoeloD, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M.A. Jarosinski, A.L. Biere, E. Curran, T. Burgess, J.C. Louis, F. Collins, J. Treanor, G. Rogers, M. Citron, β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science 286 (1999) 735-741.
17. P.R. Wenham, W.H. Price, G. Blundell, Apolipoprotein E genotyping by one-stage PCR, Lancet 337 (1991) 1158-1159.
18. R. Yan, M.J. Bienkowsi, M.E. Shuck, H. Miao, M. Tory, A.M. Pauley, N.C. Stratman, W.R. Mathews, A.E. Buhl, D.B. Carter, A.G. Tomasselli, L.A. Parodi, R.L. Heinrikson, M.E. Gurney, Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity, Nature 402 (1999) 533-537.